- Home
- EZGO vs CYCC Comparison
EZGO vs CYCC Comparison
Compare EZGO & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- CYCC
- Stock Information
- Founded
- EZGO 2014
- CYCC 1992
- Country
- EZGO China
- CYCC Malaysia
- Employees
- EZGO N/A
- CYCC N/A
- Industry
- EZGO Motor Vehicles
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- CYCC Health Care
- Exchange
- EZGO Nasdaq
- CYCC Nasdaq
- Market Cap
- EZGO 1.8M
- CYCC 7.8M
- IPO Year
- EZGO 2021
- CYCC N/A
- Fundamental
- Price
- EZGO $0.34
- CYCC $3.75
- Analyst Decision
- EZGO
- CYCC
- Analyst Count
- EZGO 0
- CYCC 0
- Target Price
- EZGO N/A
- CYCC N/A
- AVG Volume (30 Days)
- EZGO 382.1K
- CYCC 465.6K
- Earning Date
- EZGO 07-01-2025
- CYCC 08-13-2025
- Dividend Yield
- EZGO N/A
- CYCC N/A
- EPS Growth
- EZGO N/A
- CYCC N/A
- EPS
- EZGO N/A
- CYCC N/A
- Revenue
- EZGO $20,895,830.00
- CYCC $14,000.00
- Revenue This Year
- EZGO N/A
- CYCC $137.21
- Revenue Next Year
- EZGO N/A
- CYCC N/A
- P/E Ratio
- EZGO N/A
- CYCC N/A
- Revenue Growth
- EZGO 18.98
- CYCC N/A
- 52 Week Low
- EZGO $0.29
- CYCC $3.08
- 52 Week High
- EZGO $1.91
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- EZGO 51.31
- CYCC 28.20
- Support Level
- EZGO $0.31
- CYCC $3.17
- Resistance Level
- EZGO $0.35
- CYCC $3.97
- Average True Range (ATR)
- EZGO 0.03
- CYCC 0.59
- MACD
- EZGO 0.00
- CYCC 1.36
- Stochastic Oscillator
- EZGO 84.26
- CYCC 36.48
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.